Brevan Howard Capital Management LP Abbott Laboratories Transaction History
Brevan Howard Capital Management LP
- $17 Billion
- Q3 2025
A detailed history of Brevan Howard Capital Management LP transactions in Abbott Laboratories stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 6,692 shares of ABT stock, worth $870,160. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,692
Previous 45,775
85.38%
Holding current value
$870,160
Previous $6.23 Million
85.61%
% of portfolio
0.01%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,639Shares Held
1.38BCall Options Held
10.3MPut Options Held
9.01M-
Vanguard Group Inc Valley Forge, PA173MShares$22.5 Billion0.36% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.1 Billion0.31% of portfolio
-
State Street Corp Boston, MA78.2MShares$10.2 Billion0.37% of portfolio
-
Capital International Investors Los Angeles, CA61.6MShares$8.01 Billion1.4% of portfolio
-
Capital Research Global Investors Los Angeles, CA38.8MShares$5.04 Billion1.02% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $228B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...